Doctor Profile
Dr. Hui Cao
Gastrointestinal Surgery
Professor · Chief Physician · Doctoral Supervisor · MD
Gastric Cancer Surgery
GISTs
Intestinal Cancer
30+ yrs
Experience
40+
SCI Papers
50+
Doctoral and Master’s Students
Expertise
Dr. Cao specializes in the clinical diagnosis and surgical treatment of gastric, colonic, and rectal cancers. He has advanced the use of Da Vinci robotic-assisted surgery for gastrointestinal tumor resection, promoting minimally invasive “NOSES-like” techniques. Dr. Cao has also led and participated in multicenter clinical studies on multi-target tyrosine kinase inhibitors (TKIs), such as ripretinib, in the treatment of GISTs. In cases of recurrent GISTs and pelvic invasive tumors, Dr. Cao has designed tailored procedures such as proximal colostomy combined with pelvic exenteration, balancing radical tumor removal with postoperative quality of life.
Professional Background
Dr. Cao has long been engaged in clinical work in general surgery, with extensive experience in the diagnosis and treatment of gastrointestinal tumors and laparoscopic surgery. He received advanced training in gastrointestinal oncology and laparoscopic surgery in Japan, gaining a deeper understanding of standardized surgical and multidisciplinary treatment approaches.
After further training at the renowned Johns Hopkins Hospital in the United States, Dr. Cao applied advanced techniques and concepts to clinical practice, leading the development of laparoscopic treatment for gastrointestinal tumors at his institution. He is currently involved in both basic and clinical research on the comprehensive surgical treatment of gastric cancer.
His research interests include the application of modern imaging in gastrointestinal oncology, perioperative management of GI tumors, treatment of gastrointestinal stromal tumors (GISTs), and postoperative nutritional support. His surgical approach is standardized and thorough, with low complication rates. Postoperative care includes appropriately selected adjuvant therapies such as chemotherapy, contributing to favorable long-term outcomes.
Awards & Honors
Outstanding Teacher, Shanghai Jiao Tong University
Outstanding Teacher, School of Medicine, Shanghai Jiao Tong University
National Outstanding Teacher (Baosteel Excellent Teacher Award)
Named one of the “Top 100 Residents’ Favorite Teachers” nationwide
“Benevolent Healer – Shanghai Outstanding Specialist Physician Award”
“Shanghai Outstanding Academic Leader”
“Shanghai Leading Talent”
Fellow of the American College of Surgeons (FACS)
Additional achievements include:
Selected for the “Hundred Talents Program” of the former Shanghai Second Medical University in 2004
Awarded “Excellent Graduate Advisor” by Shanghai Jiao Tong University School of Medicine in 2005
Principal Investigator of the Shanghai Jiao Tong University Excellent Course in Surgery in 2010
Received the “Outstanding Teacher” title from Shanghai Jiao Tong University in 2011
Led the “Outstanding Teaching Team” project at Shanghai Jiao Tong University in 2011
Led the “Outstanding Surgical Ward” demonstration project at Shanghai Jiao Tong University in 2011
Principal Investigator of the “Excellent Course in Surgery” project funded by the Shanghai Municipal Education Commission in 2011
Named “Outstanding Academic Leader of Shanghai” in 2013
Recent Key Publications:
Ni B , He X , Zhang Y ,et al.Tumor-associated macrophage-derived GDNF promotes gastric cancer liver metastasis via a GFRA1-modulated autophagy flux[J].Cellular oncology, 2023.DOI:10.1007/s13402-022-00751-z.
Xia X , Wang S , Ni B ,et al.Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1 alpha positive feedback loop (vol 39, pg 6231, 2020)[J].Oncogene, 2021(41):40.
Zhang H , Wang Z , Dai Z ,et al.Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer[J].Frontiers in Immunology, 2021, 12:3486-.DOI:10.3389/fimmu.2021.694490.
Zhu C C , Cao H , Berlth F ,et al.Pylorus-preserving gastrectomy for early cancer involving the upper third: can we go higher?[J].Gastric Cancer, 2019.DOI:10.1007/s10120-018-00921-9.
Cao H , Yan D , Zhang S ,et al.Analysis of Dynamics of Recurrent Epidemics: Periodic or Non-periodic[J].Bulletin of Mathematical Biology, 2019, 81(1).DOI:10.1007/s11538-019-00638-5.
Zhu C C , Kim T H , Berlth F ,et al.Clinical outcomes of intraoperative manual dilatation of pylorus in pylorus-preserving gastrectomy: a retrospective analysis[J].Gastric Cancer, 2018.DOI:10.1007/s10120-018-0814-1.
Hohenberger P , Zhao W , Deligianni M ,et al.Analysis of tumor-infiltrating immune cells in gastrointestinal stromal tumors (GIST) after tyrosine kinase inhibitor therapy.[J].Journal of Clinical Oncology, 2017,35(15_suppl):11042-11042.DOI:10.1200/JCO.2017.35.15_suppl.11042.
Gu L , Xu Q , Cao H .1,25(OH)2D3 Protects Liver Fibrosis Through Decreasing the Generation of TH17 Cells[J].Medical science monitor: international medical journal of experimental and clinical research, 2017, 23:2049-2058.DOI:10.12659/MSM.904271.
Zhang Z Z , Zhao G , Zhuang C ,et al.Long non-coding RNA LINC00628 functions as a gastric cancer suppressor via long-range modulating the expression of cell cycle related genes[J].Scientific Reports, 2016, 6:27435.DOI:10.1038/srep27435.
Zhao E H , Ling T L , Cao H .Current status of surgical treatment of gastric cancer in the era of minimally invasive surgery in China: Opportunity and challenge[J].International Journal of Surgery, 2016:45-50.DOI:10.1016/j.ijsu.2016.02.027.
Zhao S , Li T , Li J ,et al.miR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway[J].Diabetologia, 2016, 59(3):644-654.DOI:10.1007/s00125-015-3832-0.
Zhao S , Li T , Li J ,et al.miR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway[J].Diabetologia, 2016.DOI:10.1007/s00125-015-3832-0.
Cao H , Yan X , Li Y ,et al.Enhancing the metal–insulator transition in VO2 heterostructures with graphene interlayers[J].Applied Physics Letters, 2022, 121(8):-.DOI:10.1063/5.0100493.
Shen Y , Cao H , Chen F ,et al.A cross‐sectional study of vitreous and serum high mobility group box‐1 levels in proliferative diabetic retinopathy[J].Acta Ophthalmologica, 2020, 98.DOI:10.1111/aos.14228.
Fang G , Cao H .State versus private provision: How does China’s market﹐riented reform affect healthcare delivery?[J].Economics of Transition and Institutional Change, 2020, 28(3).DOI:10.1111/ecot.12239.
Yan D , Cao H , Zhang S .Global dynamics for a TB transmission model with age-structure and delay[J].International Journal of Biomathematics, 2020(242):2050055.DOI:10.1142/S1793524520500552.
Cao H , Gao X , Yan D ,et al.The dynamics of an age‐structured TB transmission model with relapse[J].Mathematical Methods in the Applied Sciences, 2020, 43(6).DOI:10.1002/mma.6156.
Shen Y , Cao H , Chen F ,et al.A cross‐sectional study of vitreous and serum high mobility group box‐1 levels in proliferative diabetic retinopathy[J].John Wiley & Sons, Ltd, 2019.DOI:10.1111/aos.14228.
Zhang Z , Cao H , Shen Y ,et al.Correlation between immunophenotype classification and clinicopathological features in chinese patients with primary gastric diffuse large B-cell lymphoma[J]. 2018.DOI:10.1007/s12253-012-9585-x.
Zhu C , Zhao G , Cao H .Clinical trials of laparoscopic gastric cancer surgery in South Korea: review and prospect[J].Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2018, 21(2):154-159.
Contact Us
We would love to speak with you.
Feel free to reach out using the below details.
Find us Here
- +1 8324667523
- services@chinahealthtrip.com
Fill out the form below!
Dr. Hui Cao
Gastrointestinal Surgery
Professor · Chief Physician · Doctoral Supervisor · MD
Gastric Cancer Surgery
GISTs
Intestinal Cancer
Experience
Doctoral and Master’s Students
SCI Papers
Expertise
Dr. Cao specializes in the clinical diagnosis and surgical treatment of gastric, colonic, and rectal cancers. He has advanced the use of Da Vinci robotic-assisted surgery for gastrointestinal tumor resection, promoting minimally invasive “NOSES-like” techniques. Dr. Cao has also led and participated in multicenter clinical studies on multi-target tyrosine kinase inhibitors (TKIs), such as ripretinib, in the treatment of GISTs. In cases of recurrent GISTs and pelvic invasive tumors, Dr. Cao has designed tailored procedures such as proximal colostomy combined with pelvic exenteration, balancing radical tumor removal with postoperative quality of life.
Professional Background
Dr. Cao has long been engaged in clinical work in general surgery, with extensive experience in the diagnosis and treatment of gastrointestinal tumors and laparoscopic surgery. He received advanced training in gastrointestinal oncology and laparoscopic surgery in Japan, gaining a deeper understanding of standardized surgical and multidisciplinary treatment approaches.
After further training at the renowned Johns Hopkins Hospital in the United States, Dr. Cao applied advanced techniques and concepts to clinical practice, leading the development of laparoscopic treatment for gastrointestinal tumors at his institution. He is currently involved in both basic and clinical research on the comprehensive surgical treatment of gastric cancer.
His research interests include the application of modern imaging in gastrointestinal oncology, perioperative management of GI tumors, treatment of gastrointestinal stromal tumors (GISTs), and postoperative nutritional support. His surgical approach is standardized and thorough, with low complication rates. Postoperative care includes appropriately selected adjuvant therapies such as chemotherapy, contributing to favorable long-term outcomes.
Awards & Honors
Outstanding Teacher, Shanghai Jiao Tong University
Outstanding Teacher, School of Medicine, Shanghai Jiao Tong University
National Outstanding Teacher (Baosteel Excellent Teacher Award)
Named one of the "Top 100 Residents’ Favorite Teachers" nationwide
"Benevolent Healer – Shanghai Outstanding Specialist Physician Award"
"Shanghai Outstanding Academic Leader"
"Shanghai Leading Talent"
Fellow of the American College of Surgeons (FACS)
Additional achievements include:
Selected for the "Hundred Talents Program" of the former Shanghai Second Medical University in 2004
Awarded "Excellent Graduate Advisor" by Shanghai Jiao Tong University School of Medicine in 2005
Principal Investigator of the Shanghai Jiao Tong University Excellent Course in Surgery in 2010
Received the "Outstanding Teacher" title from Shanghai Jiao Tong University in 2011
Led the "Outstanding Teaching Team" project at Shanghai Jiao Tong University in 2011
Led the "Outstanding Surgical Ward" demonstration project at Shanghai Jiao Tong University in 2011
Principal Investigator of the "Excellent Course in Surgery" project funded by the Shanghai Municipal Education Commission in 2011
Named "Outstanding Academic Leader of Shanghai" in 2013
Professional Background
Contact Us
We would love to speak with you.
Feel free to reach out using the below details.
Find us Here
- +1 8324667523
- services@chinahealthtrip.com